One of the most commonly used cholesterol drugs could help protect cancer patients from a debilitating cognitive side effect.
About 75 per cent of cancer patients experience cognitive changes during treatment known as “chemo brain”, with 35 per cent of people suffering long-lasting symptoms, according to Cancer Research UK.